Oklo Just Cleared DOE's Final Safety Hurdle-July Criticality Now Has the Market in FOMO Mode

DOE safety approval moves Groves into the execution phase

With DOE's final major safety approval behind it, Oklo's Groves project has moved into its final pre-startup phase. The remaining steps are straightforward: DOE readiness review, fuel loading, and criticality in July. That is why the stock is no longer trading on narrative alone. It is now being judged against a near-term schedule.

If criticality happens on time, investors get concrete proof of execution. If it slips, sentiment can reverse quickly.

The 10-month pace gives the story more credibility

Oklo moved from groundbreaking to DOE startup authorization in just over 10 months, while procuring fuel and major equipment from commercial suppliers. In nuclear, that speed stands out. Bulls can read it as evidence of a repeatable operating template rather than a one-off announcement. Bears can fairly note that a test reactor still does not equal revenue.

The stock's recent move also shows that investors already understand the upside case. Oklo fell 31% during the first three months of 2026, then rebounded sharply in April. That means the market is no longer paying just for theory; it is paying for delivery.

Why the approval changes the near-term debate

The risk shift is from concept to schedule

With the Documented Safety Analysis approved, Groves has cleared DOE's final major safety approval. Practically, that advances the project toward startup, fuel loading, and July criticality. For valuation, the shift matters: investors can start underwriting a timetable instead of only a vision.

That does not remove commercial risk. Oklo is still pre-revenue, and commercialization is not expected until late 2027 or early 2028. But the approval does tighten the link between story and proof.

Startup authorization makes the next steps concrete

Startup authorization allows Oklo to load nuclear fuel, conduct startup testing, and move toward first criticality. More important, Groves is designed to build operating experience that Oklo says it can draw on for future commercial projects. In other words, the value of this step is not just the headline. It is whether Oklo can repeat the process with better confidence in schedule and cost.

If July arrives cleanly, investors do not just get confirmation that Groves can start up. They get evidence that Oklo can de-risk its broader rollout step by step.

How to watch the trade from here

Follow the proof sequence, not the headline

Trade this as a milestone ladder rather than a headline chase. Oklo now has startup authorization, which clears the way for fuel loading and then criticality. That sequence is what matters most from here.

If each step lands on time, the market can start treating prior momentum as repeatable execution rather than a one-off move. If the timeline slips, the debate simply resets to schedule risk and pre-revenue uncertainty.

What to watch next

• Timely fuel loading
• Clear progress toward July criticality
• Any signs that the schedule is slipping back into uncertainty

That last point matters because Oklo is still pre-revenue, with commercialization not expected until late 2027 or early 2028. So the disciplined approach is simple: stay engaged into the next milestones, but let conviction grow only if the operating evidence keeps arriving.